In Vitro and in Vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 12, 2009, Pages 5201-5210

  Chintalapati, Madhavi ^a   Truax, Robert ^a   Stout, Rhett ^b   Portier, Ralph ^a   Losso, Jack N ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Angiogenesis; Autophagy; Beclin 1; Breast cancer cells; Ceramide methylaminoethylphosphonate; I kb; Matrigel plug assay; NF kB; PI3K; VEGF

Indexed keywords

2 AMINOETHYLPHOSPHONIC ACID; ANGIOGENESIS INHIBITOR; CERAMIDE; CERAMIDE N METHYLAMINOETHYLPHOSPHONATE; CERAMIDE N-METHYLAMINOETHYLPHOSPHONATE; DRUG DERIVATIVE; HORMONE; VASCULOTROPIN A;

ANIMAL; APOPTOSIS; ARTICLE; BREAST TUMOR; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DOWN REGULATION; DRUG EFFECT; FEMALE; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); OYSTER; RAT; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

AMINOETHYLPHOSPHONIC ACID; ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CERAMIDES; CRASSOSTREA; DOWN-REGULATION; FEMALE; HORMONES; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

CRASSOSTREA VIRGINICA; OSTREIDAE;

EID: 67649158905     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf803818y     Document Type: Article

References (38)

1. Simon, G.; Rouser, G. Phospholipids of the sea anemone: Quantitative distribution; absence of carbon-phosphorus linkages in glycerol phospholipids; structural elucidation of ceramide aminoethylphosphonate. Lipids 1967, 2, 55-59.
2. Matsubara, T. The structure and distribution of ceramide aminoethylphosphonate in the oyster (Ostrea gigas). Biochim. Biophys. Acta 1975, 388, 353-360.
3. Matsubara, T.; Morita, M.; Hayashi, A. Determination of the presence of ceramide aminoethylphosphonate and ceramide N-methylaminoethylphosphonate in marine animals by fast atom bombardment mass spectrometry. Biochim. Biophys. Acta 1990, 1042, 280-286.
4. Kariotoglou, D. M.; Mastronicolis, S. K. Sphingophospholipid molecular species from edible mollusks and a jellyfish. Comp. Biochem. Physiol. 2003,136, 27-44.
5. de Souza, L. M.; Iacomini, M.; Gorin, P. A.; Sari, R. S.; Haddad, M. A.; Sassaki, G. L. Glyco- and sphingophosphonolipids from the medusa Phyllorhiza punctata: NMR and ESI-MS/MS fingerprints. Chem. Phys. Lipids 2007,145, 85-96.
6. Zhukova, N. V. Lipid classes and fatty acid composition of the tropical nudibranch mollusks Chromodoris sp. and Phyllidia coelestis. Lipids 2007, 42, 1169-1175.
7. Tamari, M.; Kandatsu, M. Occurrence of ceramide aminoethylphosphonate in edible shellfish, AGEMAKI, Sinonovacula constricta. Agric. Biol. Chem. 1986, 50, 1495-1501.
8. Mukhamedova, K. S.; Glushenkova, A. I. Natural phosphonolipids. Chem. Nat. Compd. 2000, 36, 329-341.
9. Karlsson, K. A.; Samuelsson, B. E. The structure of ceramide aminoethylphosphonate from the sea anemone, Metridium senile. Biochim. Biophys. Acta 1974, 337, 204-213.
10. Matsubara, T.; Hayashi, A. Identification of molecular species of ceramide aminoethylphosphonate from oyster adductor by gas-liquid chromatography-mass spectrometry. Biochim. Biophys. Acta 1973, 295,171-178.
11. (l l)Radin, N. S. Killing tumors by ceramide-induced apoptosis: A critique of available drugs. Biochem. J. 2003, 371, 243-256.
12. Shabbits, J. A.; Mayer, L. D. High ceramide content liposomes with in vivo antitumor activity. Anticancer Res. 2003, 23, 36633669.
13. Struckhoff, A. P.; Bittman, R.; Burow, M. E.; Clejan, S.; Elliott, S.; Hammond, T.; Tang, Y.; Beckman, B. S. Novel ceramide analogs as potential chemotherapeutic agents in breast cancer. J. Pharm. Exp. Ther. 2004, 309, 523-532.
14. Ogretmen, B.; Hannun, Y. A. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev. Cancer 2004, 4, 604-616.
15. Saddoughi, S. A.; Song, P.; Ogretmen, B. Roles of bioactive sphingolipids in cancer biology and therapeutics. Subcell. Biochem. 2008,49,413-440.
16. Saito, H. Lipid and FA composition of the pearl oyster Pinctada fucata martensii: Influence of season and maturation. Lipids 2004, 39, 997-1005.
17. Paglin, S.; Hollister, T.; Delohery, T.; Hackett, N.; McMahill, M.; Sphicas, E.; Domingo, D.; Yahalom, J. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 2001, 61, 439-444.
18. Arthur, C. R.; Gupton, J. T.; Kellogg, G. E.; Yeudall, W. A.; Cabot, M. C; Newsham, I. F.; Gewirtz, D. A. Autophagic cell death, polyploidy and senescence induced in breast tumor cells by the substituted pyrrole JG-03-14, a novel microtubule poison. Biochem. Pharmacol. 2007, 74, 981-991.
19. Kottke, T. J.; Blajeski, A. L.; Meng, X. W.; Svingen, P. A.; Ruchaud, S.; Mesner, P. W.Jr.; Boerner, S. A.; Samejima, K.; Henriquez, N. V.; Chilcote, T. J.; Lord, J.; Salmon, M.; Earnshaw, W. C; Kaufmann, S. H. Lack of correlation between caspase activation and caspase activity assays in paclitaxel-treated MCF-7 breast cancer cells. J. Biol. Chem. 2002, 277, 804-815.
20. Prunet, C; Lemaire-Ewing, S.; Ménétrier, F.; Néel, D.; Lizard, G. Activation of caspase-3-dependent and -independent pathways during 7-ketocholesterol- and 7β-hydroxycholesterol-induced cell death: A morphological and biochemical study. J. Biochem. MoI. Toxicol. 2005, 79,311-326.
21. Janicke, R. U.; Sprengart, M. L.; Wati, M. R.; Porter, A. G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 1998, 273, 9357-9360.
22. Yu, L.; Alva, A.; Su, H.; Dutt, P.; Freundt, E.; Welsh, S.; Baehrecke, E. H.; Leonardo, M. J. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004, 304,1500-1502.
23. Moretti, L.; Yang, E. S.; Kim, K. W.; Lu, B. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy. Drug Resist. Updates 2007,10, 135-143.
24. Georgakis, G. V.; Li, Y.; Rassidakis, G. Z.; Martinez-Valdez, H.; Medeiros, L. J.; Younes, A. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death. Clin. Cancer Res. 2006,12, 584-590.
25. Klionsky, D. J.; et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008,4, 151-175.
26. Scaralatti, F.; Bauvy, C; Ventrutti, A.; Sala, G.; Cluzeaud, F.; Vandewalle, A.; Ghindoni, R.; Codogno, P. Ceramide-mediated macroautophagy involves inhibition of protein kinase B and upregulation of beclin I. J. Biol. Chem. 2004, 279, 18384-18391.
27. Lockshin, R. A.; Zakeri, Z. Apoptosis, autophagy, and more. Int. J. Biochem. Cell Biol. 2004, 36, 2405-2419.
28. Vandenabeele, P.; Vanden Berghe, T.; Festjens, N. Caspase inhibitors promote alternative cell death pathways. Sci. STKE 2006, 358, No. e44.
29. Liang, X. H.; Jackson, S.; Seaman, M.; Brown, K.; Kempkes, B.; Hibshoosh, H.; Levine, B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402, 672-676.
30. Wang, Z. H.; Xu, L.; Duan, Z. L.; Zeng, L. Q.; Yan, N. H.; Peng, Z. L. Beclin 1-mediated macroautophagy involves regulation of caspase-9 expression in cervical cancer HeLa cells. Gynecol. Oncol. 2007,107,107- 113.
31. Pattingre, S.; Tassa, A.; Qu, X.; Garuti, R.; Liang, X. H.; Mizushima, N.; Packer, M.; Schneider, M. D.; Levine, B. Bcl-2 antiapoptotic proteins inhibit beclin 1-dependent autophagy. Cell 2005,122, 927-939.
32. kB transcription factor and reactives oxygen species. Autophagy 2007, 3, 390-392.
33. Simstein, R.; Burow, M.; Parker, A.; Weldon, C; Beckman, B. Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Exp. Biol. Med. 2003, 228, 995-1003.
34. Coward, J.; Ambrosini, G.; Musi, E.; Truman, J. P.; Haimovitz-Friedman, A.; Allegood, J. C; Wang, E.; Merrill, A. HJr.; Schwartz, G. K. Safingol (L-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway. Autophagy 2009, 5,184-193.
35. Lauener, R.; Shen, Y.; Duronio, V.; Salari, H. Selective inhibition of phosphatidylinositol 3-kinase by phosphatidic acid and related lipids. Biochem. Biophys. Res. Commun. 1995, 215, 8-14.
36. Lavieu, G.; Scarlatti, F.; Sala, G.; Carpentier, S.; Levade, T.; Ghidoni, R.; Botti, J.; Codogno, P. Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation. J. Biol. Chem. 2006, 281, 8518-8527.
37. Fillet, M.; Bentires-Alj, M.; Deregowski, V.; Greimers, R.; Gielen, J.; Piette, J.; Bours, V.; Merville, M. P. Mechanisms involved in exogenous C2- and C6-ceramide-induced cancer cell toxicity. Biochem. Pharmacol. 2003, 65, 1633-1642.
38. Bansode, R. R. In vitro and in vivo anti-angiogenic activities of milk sphingolipids. Ph.D. Dissertation, Louisiana State Univerity, Baton Rouge, LA, Oct 2005.